This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Block & Leviton LLP Investigates Blue Coat Systems, Inc.'s Board Of Directors For Possible Breaches Of Fiduciary Duty

BOSTON, Dec. 9, 2011 /PRNewswire/ -- Block & Leviton LLP ( www.blockesq.com), a Boston-based law firm representing investors nationwide, has commenced an investigation into possible breaches of fiduciary duties by the Board of Directors of Blue Coat Systems, Inc. ("Blue Coat" or the "Company") (Nasdaq: BCSI) with regards to the proposed acquisition of the Company by an investor group headed by Thoma Bravo LLC. The transaction is for $25.81 per share, or a net purchase price of $1.3 billion.

Block & Leviton's investigation seeks to determine, among other things, whether Blue Coat's Directors breached their fiduciary duties by failing to maximize shareholder value in the proposed transaction. Blue Coat's stock has traded significantly higher than the offer price, reaching the low $30 range as recently as February 2011. Moreover, the offer price represents only a 14 percent premium over Blue Coat's average daily share price over the last year.

If you are a Blue Coat shareholder and have questions about your legal rights, please contact Block & Leviton at (617) 398-5600 or email us at info@blockesq.com.

Block & Leviton is a Boston-based law firm representing investors for violations of securities laws.  The firm's lawyers have collectively been prosecuting securities cases on behalf of investors for over 40 years.

This notice may constitute attorney advertising.

SOURCE Block & Leviton LLP

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,123.34 -39.65 -0.22%
S&P 500 2,120.76 -2.72 -0.13%
NASDAQ 5,097.6070 -8.9860 -0.18%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs